Sterling Capital Management LLC Uro Gen Pharma Ltd. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Sterling Capital Management LLC holds 52 shares of URGN stock, worth $632. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52Holding current value
$632% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
129Shares Held
38.3MCall Options Held
158KPut Options Held
161K-
Rtw Investments, LP New York, NY3.79MShares$46.1 Million0.77% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.74MShares$45.4 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.08MShares$37.5 Million0.78% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.45MShares$29.8 Million0.11% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$28 Million0.19% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $277M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...